Secretary's Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting, 955-956 [2013-00028]
Download as PDF
<![CDATA[
955
Federal Register / Vol. 78, No. 4 / Monday, January 7, 2013 / Notices
Information Collection Request Title:
HRSA Environmental Information and
Documentation (EID) (OMB No. 0915–
0324)—Revision
Abstract: HRSA is requesting an
extension of the approval for the
Environmental Information and
Documentation (EID) checklist, which
consists of information that the agency
is required to obtain to comply with the
National Environmental Policy Act of
1969 (NEPA). NEPA establishes the
federal government’s national policy for
protection of the environment. HRSA
has developed the EID for applicants of
funding that would potentially impact
the environment and to ensure that their
decision-making processes are
consistent with NEPA. Applicants must
provide information and assurance of
compliance with NEPA on the EID
checklist. The estimated annual burden
is as follows:
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions, to
develop, acquire, install and utilize
Number of
respondents
Form name
Responses
per
respondent
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information, to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information, and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
The annual estimate of burden is as
follows:
Total
responses
Hours per
response
Total
burden
hours
NEPA EID Checklist ............................................................
1,847
1
1,847
.75
1,385.25
Total ..............................................................................
1,847
1
1,847
.75
1,385.25
Submit your comments to
the desk officer for HRSA, either by
email to
OIRA_submission@omb.eop.gov or by
fax to 202–395–5806. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Deadline: Comments on this ICR
should be received within 30 days of
this notice.
ADDRESSES:
Dated: December 28, 2012.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–00029 Filed 1–4–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Secretary’s Advisory Committee on
Heritable Disorders in Newborns and
Children; Notice of Meeting
wreier-aviles on DSK7SPTVN1PROD with
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463, codified at 5 U.S.C.
App. 2), notice is hereby given of the
following meeting:
Name: Secretary’s Advisory Committee on
Heritable Disorders in Newborns and
Children (SACHDNC).
Dates and Times: January 31, 2013, 9:30
a.m. to 5:00 p.m., February 1, 2013, 9:30 a.m.
to 1:15 p.m.
Place: Virtual via Webinar.
Status: The meeting is open to the public.
For more information on registration and
webinar details, please visit the SACHDNC
Web site: https://www.hrsa.gov/
VerDate Mar<15>2010
15:16 Jan 04, 2013
Jkt 229001
advisorycommittees/mchbadvisory/
heritabledisorders.
Purpose: The Secretary’s Advisory
Committee on Heritable Disorders in
Newborns and Children (SACHDNC), as
authorized by Public Law 106–310, which
added section 1111 of the Public Health
Service Act, codified at 42 U.S.C. 300b–10,
was established by Congress to advise the
Secretary of the Department of Health and
Human Services regarding the development
of newborn screening activities, technologies,
policies, guidelines, and programs for
effectively reducing morbidity and mortality
in newborns and children having, or at risk
for, heritable disorders. The SACHDNC’s
recommendations regarding additional
conditions/inherited disorders for screening
that have been adopted by the Secretary are
included in the Recommended Uniform
Screening Panel (RUSP) that constitutes part
of the comprehensive guidelines supported
by the Health Resources and Services
Administration. Pursuant to section 2713 of
the Public Health Service Act, codified at 42
U.S.C. 300gg–13, non-grandfathered health
plans are required to cover screenings
included in the comprehensive guidelines
without charging a co-payment, co-insurance,
or deductible for plan years (i.e., policy
years) beginning on or after the date that is
one year from the Secretary’s adoption of the
condition for screening. The SACHDNC also
provides advice and recommendations
concerning grants and projects authorized
under section 1109 of the Public Health
Service Act (42 U.S.C. 300b–8).
Agenda: The meeting will include: (1)
Updates on state implementation of newborn
screening for Critical Congenital Heart
Disease (CCHD) and Severe Combined
Immunodeficiency Disorder (SCID); (2)
update on the Pompe Condition Nomination;
(3) update on application of the SACHDNC
Condition Review Matrix; (4) updates on
priority projects from the Advisory
Committee’s subcommittees on Laboratory
Standards and Procedures, Follow-up and
Treatment, and Education and Training; (5)
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
a presentation on the Duchenne Muscular
Dystrophy Newborn Screening Symposium;
(6) a final workgroup report on carrier
screening; and (7) a presentation on the
National Institutes of Health’s Genomic
Sequencing and Newborn Screening
Disorders Initiative.
Tentatively, the SACHDNC is expected to
vote on: (1) A finalized report regarding
genetic carrier screening (i.e., testing to
identify individuals who may be at increased
risk of carrying one or more gene mutations
that could result in having children affected
with an inherited genetic disorder); and (2)
application of the Condition Review Decision
Matrix.
Proposed agenda items are subject to
change as priorities dictate. The agenda,
webinar information, Committee Roster,
Charter, presentations, and meeting materials
are located on the Advisory Committee’s Web
site at https://www.hrsa.gov/
advisorycommittees/mchbadvisory/
heritabledisorders.
Public Comments: Members of the public
can submit written comments and/or register
to present oral comments during the public
comment period of the meeting. All
comments, whether oral or written, are part
of the official Committee record and will be
available for public inspection and copying.
Advanced registration is required to present
oral comments or submit written comments.
Individuals who wish to make public
comments are required to email Lisa Vasquez
(lvasquez@hrsa.gov) by Thursday, January
17, 2013. The public comment period is
scheduled for the morning of January 31,
2013.
Written comments should identify the
individual’s name, address, email, telephone
number, professional or business affiliation,
type of expertise (i.e., parent, researcher,
clinician, public health, etc.), and the topic/
subject matter of comment. To ensure that all
individuals who have registered to make oral
comments can be accommodated, the
allocated time may be limited. Individuals
who are associated with groups or have
E:\FR\FM\07JAN1.SGM
07JAN1
956
Federal Register / Vol. 78, No. 4 / Monday, January 7, 2013 / Notices
similar interests may be requested to
combine their comments and present them
through a single representative. No
audiovisual presentations are permitted.
Contact Person: Anyone interested in
obtaining other relevant information should
contact Patrick Stephens, Maternal and Child
Health Bureau, Health Resources and
Services Administration, Room 18A–19,
Parklawn Building, 5600 Fishers Lane,
Rockville, Maryland 20857; telephone: 301–
443–1080; email: pstephens@hrsa.gov.
More information on the Advisory
Committee is available at https://
www.hrsa.gov/advisorycommittees/
mchbadvisory/heritabledisorders.
Dated: December 28, 2012.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–00028 Filed 1–4–13; 8:45 am]
Dated: December 26, 2012.
Mary K. Wakefield,
Administrator.
BILLING CODE 4165–15–P
[FR Doc. 2013–00027 Filed 1–4–13; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4165–15–P
Health Resources and Services
Administration
wreier-aviles on DSK7SPTVN1PROD with
National Vaccine Injury Compensation
Program: Revised Amount of the
Average Cost of a Health Insurance
Policy
The Health Resources and Services
Administration (HRSA) is publishing an
updated monetary amount of the
average cost of a health insurance policy
as it relates to the National Vaccine
Injury Compensation Program (VICP).
Section 100.2 of the VICP’s
implementing regulation (42 CFR Part
100) states that the revised amounts of
an average cost of a health insurance
policy, as determined by the Secretary,
are to be published periodically in a
notice in the Federal Register and filed
with the United States Court of Federal
Claims (the Court). This figure is
calculated using the most recent
Medical Expenditure Panel SurveyInsurance Component (MEPS–IC) data
available as the baseline for the average
monthly cost of a health insurance
policy. This baseline is adjusted by the
annual percentage increase/decrease
obtained from the most recent annual
Kaiser Family Foundation and Health
Research and Educational Trust (KFF/
HRET) Employer Health Benefits survey
or other authoritative source that may be
more accurate or appropriate.
In 2012, MEPS–IC, available at
www.meps.ahrq.gov, published the
annual 2011 average total single
premium per enrolled employee at
private-sector establishments that
provide health insurance. The annual
figure published was $5,222. This figure
is divided by 12 months to determine
VerDate Mar<15>2010
15:16 Jan 04, 2013
Jkt 229001
the cost per month of $435.17. The
$435.17 shall be increased or decreased
by the percentage change reported by
the most recent KFF/HRET, available at
www.kff.org. The percentage increase
was published at 3 percent. By adding
this percentage increase, the calculated
average monthly cost of a health
insurance policy for a 12 month period
is $448.23.
Therefore, the Secretary announces
that the revised average cost of a health
insurance policy under the VICP is
$448.23 per month. In accordance with
§ 100.2, the revised amount was
effective upon its delivery by the
Secretary to the Court. Such notice was
delivered to the Court on November 30,
2012.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Statement of Organization, Functions
and Delegations of Authority
This notice amends Part R of the
Statement of Organization, Functions
and Delegations of Authority of the
Department of Health and Human
Services (HHS), Health Resources and
Services Administration (HRSA) (60 FR
56605, as amended November 6, 1995;
as last amended at 77 FR 65694–65698
dated October 30, 2012).
This notice reflects organizational
changes to the Health Resources and
Services Administration. This notice
updates the functional statements for
the Office of Management (RB4) and
Office of Information Technology (RB5).
Specifically, this notice: (1) Transfers
the records management function from
the Office of Management (RB4) to the
Office of Information Technology (RB5);
(2) updates the functional statement for
the Office of Management (RB4) and the
Office of the Director and Chief
Information Officer, Office of
Information Technology; and (3)
establishes the Division of Information
Technology (IT) Security and Records
Management (RBR) within the Office of
Information Technology (RB5).
Chapter RB4—Office of Management
Section RB4–20, Functions
(1) Delete the functional statement for
the Office of Management (RB4) and
replace in its entirety.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Office of Management (RB4)
Provides HRSA-wide leadership,
program direction, and coordination of
all phases of administrative
management. Specifically, the Office of
Management: (1) Provides management
expertise, staff advice, and support to
the Administrator in program and
policy formulation and execution; (2)
provides administrative management
services including human resources,
property management, space planning,
safety, physical security, and general
administrative services; (3) conducts
HRSA-wide workforce analysis studies
and surveys; (4) plans, directs, and
coordinates HRSA’s activities in the
areas of human resources management,
including labor relations, personnel
security, and performance; (5)
coordinates the development of
administrative policies and regulations;
(6) oversees the development of annual
operating objectives and coordinates
HRSA work planning and appraisals; (7)
directs and coordinates HRSA’s
organizations, functions, and
delegations of authority programs; (8)
administers the Agency’s Executive
Secretariat and committee management
functions; (9) provides staff support to
the Agency Chief Travel Official; (10)
provides staff support to the Deputy
Ethics Counselor; and (11) directs,
coordinates, and conducts workforce
development activities for HRSA.
Chapter RB5—Office of Information
Technology
Section RB5–10, Organization
Delete in its entirety and replace with
the following:
The Office of Information Technology
(RB5) is headed by the Director and
Chief Information Officer within the
Office of Operations, Health Resources
and Services Administration, who
reports directly to the Chief Operating
Officer. The Office of Information
Technology includes the following
components:
(1) Office of the Director and Chief
Information Officer (RB5);
(2) Division of Capital Planning,
Architecture and Project Management
(RB52);
(3) Division of Data and Information
Services (RB55);
(4) Division of Enterprise Solutions
and Applications Management (RB56);
(5) Division of IT Management
Support Services (RB57);
(6) Division of IT Operational Support
Services (RB58);
(7) Division of Web Support and
Collaboration Services (RB59); and
(8) Division of IT Security and
Records Management (RBR).
E:\FR\FM\07JAN1.SGM
07JAN1
]]>Agencies
[Federal Register Volume 78, Number 4 (Monday, January 7, 2013)]
[Notices]
[Pages 955-956]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00028]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Secretary's Advisory Committee on Heritable Disorders in Newborns
and Children; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Public Law 92-463, codified at 5 U.S.C. App. 2), notice
is hereby given of the following meeting:
Name: Secretary's Advisory Committee on Heritable Disorders in
Newborns and Children (SACHDNC).
Dates and Times: January 31, 2013, 9:30 a.m. to 5:00 p.m.,
February 1, 2013, 9:30 a.m. to 1:15 p.m.
Place: Virtual via Webinar.
Status: The meeting is open to the public. For more information
on registration and webinar details, please visit the SACHDNC Web
site: https://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Purpose: The Secretary's Advisory Committee on Heritable
Disorders in Newborns and Children (SACHDNC), as authorized by
Public Law 106-310, which added section 1111 of the Public Health
Service Act, codified at 42 U.S.C. 300b-10, was established by
Congress to advise the Secretary of the Department of Health and
Human Services regarding the development of newborn screening
activities, technologies, policies, guidelines, and programs for
effectively reducing morbidity and mortality in newborns and
children having, or at risk for, heritable disorders. The SACHDNC's
recommendations regarding additional conditions/inherited disorders
for screening that have been adopted by the Secretary are included
in the Recommended Uniform Screening Panel (RUSP) that constitutes
part of the comprehensive guidelines supported by the Health
Resources and Services Administration. Pursuant to section 2713 of
the Public Health Service Act, codified at 42 U.S.C. 300gg-13, non-
grandfathered health plans are required to cover screenings included
in the comprehensive guidelines without charging a co-payment, co-
insurance, or deductible for plan years (i.e., policy years)
beginning on or after the date that is one year from the Secretary's
adoption of the condition for screening. The SACHDNC also provides
advice and recommendations concerning grants and projects authorized
under section 1109 of the Public Health Service Act (42 U.S.C. 300b-
8).
Agenda: The meeting will include: (1) Updates on state
implementation of newborn screening for Critical Congenital Heart
Disease (CCHD) and Severe Combined Immunodeficiency Disorder (SCID);
(2) update on the Pompe Condition Nomination; (3) update on
application of the SACHDNC Condition Review Matrix; (4) updates on
priority projects from the Advisory Committee's subcommittees on
Laboratory Standards and Procedures, Follow-up and Treatment, and
Education and Training; (5) a presentation on the Duchenne Muscular
Dystrophy Newborn Screening Symposium; (6) a final workgroup report
on carrier screening; and (7) a presentation on the National
Institutes of Health's Genomic Sequencing and Newborn Screening
Disorders Initiative.
Tentatively, the SACHDNC is expected to vote on: (1) A finalized
report regarding genetic carrier screening (i.e., testing to
identify individuals who may be at increased risk of carrying one or
more gene mutations that could result in having children affected
with an inherited genetic disorder); and (2) application of the
Condition Review Decision Matrix.
Proposed agenda items are subject to change as priorities
dictate. The agenda, webinar information, Committee Roster, Charter,
presentations, and meeting materials are located on the Advisory
Committee's Web site at https://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Public Comments: Members of the public can submit written
comments and/or register to present oral comments during the public
comment period of the meeting. All comments, whether oral or
written, are part of the official Committee record and will be
available for public inspection and copying. Advanced registration
is required to present oral comments or submit written comments.
Individuals who wish to make public comments are required to email
Lisa Vasquez (lvasquez@hrsa.gov) by Thursday, January 17, 2013. The
public comment period is scheduled for the morning of January 31,
2013.
Written comments should identify the individual's name, address,
email, telephone number, professional or business affiliation, type
of expertise (i.e., parent, researcher, clinician, public health,
etc.), and the topic/subject matter of comment. To ensure that all
individuals who have registered to make oral comments can be
accommodated, the allocated time may be limited. Individuals who are
associated with groups or have
[[Page 956]]
similar interests may be requested to combine their comments and
present them through a single representative. No audiovisual
presentations are permitted.
Contact Person: Anyone interested in obtaining other relevant
information should contact Patrick Stephens, Maternal and Child
Health Bureau, Health Resources and Services Administration, Room
18A-19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland
20857; telephone: 301-443-1080; email: pstephens@hrsa.gov.
More information on the Advisory Committee is available at
https://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Dated: December 28, 2012.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-00028 Filed 1-4-13; 8:45 am]
BILLING CODE 4165-15-P
